Suppr超能文献

FK506聚酮合酶的一个酰基转移酶结构域,可同时识别酰基载体蛋白和辅酶A作为酰基供体,以转移烯丙基丙二酰基和乙基丙二酰基单元。

An acyltransferase domain of FK506 polyketide synthase recognizing both an acyl carrier protein and coenzyme A as acyl donors to transfer allylmalonyl and ethylmalonyl units.

作者信息

Jiang Hui, Wang Yue-Yue, Guo Yuan-Yang, Shen Jie-Jie, Zhang Xiao-Sheng, Luo Hong-Dou, Ren Ni-Ni, Jiang Xin-Hang, Li Yong-Quan

机构信息

College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.

Key Laboratory of Microbial Biochemistry and Metabolism Engineering of Zhejiang Province, Hangzhou, Zhejiang, China.

出版信息

FEBS J. 2015 Jul;282(13):2527-39. doi: 10.1111/febs.13296. Epub 2015 Apr 30.

Abstract

UNLABELLED

Acyltransferase (AT) domains of polyketide synthases (PKSs) usually use coenzyme A (CoA) as an acyl donor to transfer common acyl units to acyl carrier protein (ACP) domains, initiating incorporation of acyl units into polyketides. Two clinical immunosuppressive agents, FK506 and FK520, are biosynthesized by the same PKSs in several Streptomyces strains. In this study, characterization of AT4FkbB (the AT domain of the fourth module of FK506 PKS) in transacylation reactions showed that AT4FkbB recognizes both an ACP domain (ACPT csA) and CoA as acyl donors for transfer of a unique allylmalonyl (AM) unit to an acyl acceptor ACP domain (ACP4FkbB), resulting in FK506 production. In addition, AT4FkbB uses CoA as an acyl donor to transfer an unusual ethylmalonyl (EM) unit to ACP4FkbB, resulting in FK520 production, and transfers AM units to non-native ACP acceptors. Characterization of AT4FkbB in self-acylation reactions suggests that AT4FkbB controls acyl unit specificity in transacylation reactions but not in self-acylation reactions. Generally, AT domains of PKSs only recognize one acyl donor; however, we report here that AT4FkbB recognizes two acyl donors for the transfer of different acyl units.

DATABASE

Nucleotide sequence data have been submitted to the GenBank database under accession numbers KJ000382 and KJ000383.

摘要

未标记

聚酮合酶(PKSs)的酰基转移酶(AT)结构域通常使用辅酶A(CoA)作为酰基供体,将常见的酰基单元转移到酰基载体蛋白(ACP)结构域,从而启动酰基单元掺入聚酮化合物的过程。两种临床免疫抑制剂FK506和FK520,由几种链霉菌菌株中的相同PKSs生物合成。在本研究中,对转酰基反应中AT4FkbB(FK506 PKS第四模块的AT结构域)的表征表明,AT4FkbB识别一个ACP结构域(ACPT csA)和CoA作为酰基供体,用于将独特的烯丙基丙二酰(AM)单元转移到酰基受体ACP结构域(ACP4FkbB),从而产生FK506。此外,AT4FkbB使用CoA作为酰基供体,将不寻常的乙基丙二酰(EM)单元转移到ACP4FkbB,从而产生FK520,并将AM单元转移到非天然的ACP受体。对AT4FkbB在自身酰化反应中的表征表明,AT4FkbB在转酰基反应中控制酰基单元特异性,但在自身酰化反应中不控制。一般来说,PKSs的AT结构域只识别一种酰基供体;然而,我们在此报告,AT4FkbB识别两种酰基供体用于转移不同的酰基单元。

数据库

核苷酸序列数据已提交至GenBank数据库,登录号为KJ000382和KJ000383。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验